Life Forward Award 2027 

 
 
 

Please make sure to check the eligibility criteria before submitting your project!


Project Submission page


Submit your project through the online submission tool available here below. We recommend to use Google Chrome when uploading your project.  


Please be informed you will need to create a user profile before being able to submit your project. Once you have created your user profile, you will be able to submit your project. 


Useful tip!


You will be able to start and save your project and submit it a a later stage when your project is totally finalised. 



   

Deadline


  • Project Submission Deadline: Monday, 04 January 2027, midnight.


Participation requirements Life Forward Award 2027


Who can apply? 

The candidate must fulfill all criteria below:


  • Young hematologists in training who are MD and are within 10 years after MD graduation 

  • OR members of the multidisciplinary hospital team involved in hematology survivorship care, including (but not limited to):

- nurses 

- nurse specialists 

- physiotherapists 

- psychologists 

- dietitians 

- social workers 

- occupational therapists 

- care coordinators 

- other allied health professionals contributing to survivorship pathways 

  • May not be an employee of the pharmaceutical industry 


Which projects are eligible?


Innovative projects that focus on improving the survivorship experience of individuals living beyond hematologic cancer treatment. Eligible initiatives may address (but are not limited to): 

  • Long‑term physical, psychological, cognitive, or social effects of hematologic cancers or their treatments 

  • Models of care that improve follow‑up, rehabilitation, or reintegration into daily life 

  • Tools or programs that enhance quality of life, patient empowerment, or self‑management 

  • Research that advances understanding of survivorship challenges or outcomes 

  • Support initiatives for patients, families, or caregivers 

  • Innovative approaches using digital health, patient‑reported outcomes, or multidisciplinary care pathways 

  • Projects should be carried out in the hospital or outpatient setting (with a clear link to a hospital environment). The project must not be directly linked to the use of a specific pharmaceutical specialty. All projects must comply with the Protection of Privacy Law. 


Application requirements?


The application must preferably be written in English** and must consist of :

​​​​​​​

  • an information form containing the different project members and including the curriculum vitae of the applicant
  • a summary in abstract format with a maximum of 2500 characters (including spaces) for possible publication in the Belgian Journal of Hematology
  • a detailed project form with a maximum of 3 pages including a budget estimate - see an example of Detailed project form for the Life Forward Award 2027


* templates are also available in the online submission tool

** applications in French or Dutch are acceptable, but the abstract/summary must be in English


Evaluation criteria: 


  • Relevance and impact of the project on improving survivorship and long‑term patient well‑being (50%) 

  • Originality of the project in addressing unmet needs in survivorship (25%) 

  • Feasibility of the project within the proposed timeframe and setting (20%) 

  • Relevance of the budgetary estimate (5%) 


Only submission through the online form is possible. Submissions sent by e-mail will not be considered.


Life Forward Award


A total cash prize award of 20.000 euros will be given to a maximum of 2 winners.

Please note, the prize money cannot be allocated to fund a salary, but it can cover activity and material costs.

The results of the Life Forward Award will be announced during the 2027 General Annual Meeting of the BHS.

The BHS Life Forward award has been made possible with an unrestricted grant from the Daiichi Sankyo.



​




​